Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis

20 Aug 2020

Abstract excerpt

The world is facing the rising emergency of SARS-CoV-2. The outbreak of COVID-19 has caused a global public health and economic crisis.Recent epidemiological studies have shown that a possible association of BCG vaccination program with decreased COVID-19-related risks, suggesting that BCG may provide protection against COVID-19. Non-specific protection against viral infections is considered as a main mechanism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Immune responses and vaccinations
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32863070
DOI: 10.1016/j.vaccine.2020.08.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesisPMID 32863070Read ↗

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-ReactivitySemantic proximity Read ↗

A study on the relationship between BCG vaccination and Covid-19 prevalence: Do other confounders warrant investigation?Semantic proximity Read ↗

Hidden in plain sight: The effects of BCG vaccination in COVID-19 pandemicSemantic proximity Read ↗

Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2.Semantic proximity Read ↗

Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population.Semantic proximity Read ↗

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in miceSemantic proximity Read ↗

Heterologous vaccine interventions: boosting immunity against future pandemicsSemantic proximity Read ↗

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effectSemantic proximity Read ↗

In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinologySemantic proximity Read ↗

Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 miceSemantic proximity Read ↗

In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosisSemantic proximity Read ↗

Insilico Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium Tuberculosis H37Rv; An Immunoinformatics ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.